Search
for
Sort by
Research 30 of 780
- Exogenous Testosterone (T) Alone or with Finasteride Increases Physical Performance, Grip Strength, and Lean Body Mass in Older Men with Low Serum T
- The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial
- Exogenous Testosterone Alone or with Finasteride Increases Physical Performance, Grip Strength, and Lean Body Mass in Older Men with Low Serum Testosterone
- 115 EXOGENOUS TESTOSTERONE ALONE OR WITH FINASTERIDE INCREASES PHYSICAL PERFORMANCE, GRIP STRENGTH, AND LEAN BODY MASS IN OLDER MEN WITH LOW SERUM TESTOSTERONE
- Myocyte Androgen Receptor Modulates Body Composition and Metabolic Parameters
- Musculoskeletal and body composition response to high-dose testosterone with finasteride after chronic incomplete spinal cord injury—a randomized, double-blind, and placebo-controlled pilot study
- Effects of Intramuscular Testosterone Undecanoate on Body Composition and Bone Mineral Density in Female-to-Male Transsexuals
- Body composition and physical fitness in transgender versus cisgender individuals: a systematic review with meta-analysis
- Predictivity of fatty liver index for non-alcoholic fatty liver disease in lean females with polycystic ovary syndrome
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
- Activation of nuclear factor κB in response to cream ingestion is related to ovarian androgen hypersecretion in polycystic ovary syndrome
- The influence of non-esterified fatty acids (NEFA) on the ovarian production of androgens in a context of in vitro fertilisation (IVF) – preliminary results
- Drug Therapy in Polycystic Ovarian Syndrome
- Anthropometric Characteristics of Polycystic Ovary Syndrome and Their Associations with Insulin Resistance and Lipid Profile
- Tissue insulin sensitivity and body weight in polycystic ovary syndrome
- Correlation of Cutaneous Manifestations With Body Mass Index (BMI) in Polycystic Ovary Syndrome (PCOS) Patients in a Tertiary Care Centre: An Observational Study
- Inflammatory and Anti-Inflammatory Parameters in PCOS Patients Depending on Body Mass Index: A Case-Control Study
- Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance
- Prevalence of hyperandrogenism in Iraqi women with polycystic ovary syndrome
- Nonalcoholic fatty liver disease in young adult Egyptian women with polycystic ovary syndrome
- Body composition changes and inhibition of fat development in vivo implicates androgen in regulation of stem cell lineage allocation
- Mechanism of action of bolandiol (19-nortestosterone-3β,17β-diol), a unique anabolic steroid with androgenic, estrogenic, and progestational activities
- A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia
- A Comparative Analysis of Serum Irisin Levels and Body Composition Indices in Women With and Without Polycystic Ovary Syndrome (PCOS)
- Testosterone+Finasteride Improves Body Composition After Spinal Cord Injury: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
- Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors
- Mechanisms of testosterone action
- Therapeutic Androgen Receptor Ligands
- Sex hormones and sarcopenia in older persons